Cancer Clinical Trial - Pfizer - C3891001

Status:

Open and enrolling

ClinicalTrials.gov:

NCT04152018

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors - CONDITION(S): Pancreatic cancer

Drug

PF-06940434

Trial Type

Treatment

Condition

Pancreatic cancer

Keywords

Pancreatic cancer | Pfizer